Similar Stories to Why Investors Are Paying A Premium For These 3 Biotech Stocks on Bing News

So far, 2018 has been full of ups and down for the biotech industry as a whole. For these three stocks, though, prices have swung so far in a positive direction that investors are paying huge premiums now. Just one of these companies has an approved product to sell but they're worth a combined $12 billion.

BING NEWS:
  • 2025 Analyst Outlook: Edmund Ingham On Biotech Big And Small, And A Key Milestone
    Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.
    12/26/2024 - 12:30 am | View Link
  • Rapt re-rolls after flameout, paying $35M for challenger to Novartis, Roche drug
    A deal with Shanghai Jemincare Pharmaceutical has filled the hole. Rapt is paying $35 million upfront, plus up to $672.5 million in milestones, for ex-China rights to a half-life extended ...
    12/22/2024 - 11:11 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News